Feature story
Drugmakers may have to disclose prices of medicine in television ads
MONDAY, October 15, 2018 (The Washington Post)—The nation’s top health official proposed on Monday that pharmaceutical companies be required to include the list price of medicines in television advertisements to consumers — the boldest in a series of efforts by the Trump administration to curb rampant drug spending.
Under a major change laid out by Health and Human Services Secretary Alex Azar and drafted as a new federal rule, drug manufacturers would need to disclose in ads the list price of a 30-day supply of any drug that is covered through Medicare and Medicaid and costs more than $35 a month.
You might have also missed…
Dense breasts and the risks of cancer
Oct. 15, The Washington Post
Researchers Want Cancer Patients To Share Their Medical Information In Search of Cures
Oct. 18, TIME
Reasons You Shouldn’t Wait Until Age 40 to Get a Mammogram
Oct. 15, Shape magazine
Smoking featured in half of hip-hop videos, study finds
Oct. 15, CNN
